Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02573207 · ClinicalTrials.gov registry record
Recovery of Hibernating Myocardium in End Stage Heart Failure
A clinical trial, sponsored by Intermountain Health Care.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02573207: Clinical Trial study, sponsored by Intermountain Health Care.
NCT02573207 is a clinical trial that was terminated before completion, run by Intermountain Health Care. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02573207 was terminated before completion, sponsored by Intermountain Health Care.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This study will collect clinical, echocardiographic, nuclear imaging and hemodynamic data in a group of patients with end stage ischemic cardiomyopathy undergoing left ventricular assist device (LVAD) implantation to investigate the incidence of recovery of myocardial function when supported with LVADs, and to study the association between hibernating myocardium and myocardial recovery in this population.
Primary Outcome
Recovery of myocardial function assessed continuously, using echocardiographic variables (LVEF, circumferential strain and strain rate, segmental strain and strain rate).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-04-09 |
Why NCT02573207 stopped before completion
NCT02573207 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02573207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02573207 about?
NCT02573207 is a clinical study titled "Recovery of Hibernating Myocardium in End Stage Heart Failure". This study will collect clinical, echocardiographic, nuclear imaging and hemodynamic data in a group of patients with end stage ischemic cardiomyopathy undergoing left ventricular assist device (LVAD) implantation to investigate the incidence of recovery of myocardial function when supported with LV...
What is the current status of trial NCT02573207?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2016-03. Estimated completion is 2019-04-09.
Who is sponsoring clinical trial NCT02573207?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia